This bill would establish a dedicated Office of Novel Therapeutics within the VA and ensure the department is prepared to safely evaluate and implement emerging therapies by establishing centralized governance, workforce readiness planning, and clinical implementation infrastructure within the Veterans Health Administration.
Establish a dedicated Office of Novel Therapeutics within the Department of Veterans Affairs to increase veterans' access to innovative health care and ensure preparedness for implementing emerging mental health therapies.
Occurrences
Evidence
On March 27, 2026, Senator Tim Sheehy introduced the bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act to establish a dedicated Office of Novel Therapeutics within the Department of Veterans Affairs. This office aims to increase veterans' access to innovative health care and ensure preparedness for implementing emerging mental health therapies.
The Veterans Health Administration Novel Therapeutics Preparedness Act, introduced as S. 4220, was read twice and referred to the Committee on Veterans' Affairs on March 26, 2026.
The Veterans Health Administration Novel Therapeutics Preparedness Act, introduced by Senator Sheehy and co-sponsored by Senators Gallego, Duckworth, and Boozman, aims to establish an Office of Novel Therapeutics within the VA to oversee and implement emerging therapies, including psychedelic treatments for mental health conditions.
Senators Gallego, Sheehy, Duckworth, and Boozman introduced the bipartisan Veterans Health Administration Novel Therapeutics Preparedness Act to establish an Office of Novel Therapeutics within the VA, ensuring the department is prepared to evaluate and implement emerging mental health therapies.
The Veterans Health Administration Novel Therapeutics Preparedness Act directs the VA to prepare for emerging therapies by establishing an Office of Novel Therapeutics, aiming to integrate these treatments into the VA healthcare system.
The Senate office’s legislation page still listed S.4220, the Veterans Health Administration Novel Therapeutics Preparedness Act, with the latest action: "Committee on Veterans' Affairs. Hearings held."
The Senate Veterans’ Affairs Committee hearing agenda for April 29, 2026 included "S.4220, the VHA Novel Therapeutics Preparedness Act (Sheehy)."
Assessments
Sheehy introduced S.4220, the Veterans Health Administration Novel Therapeutics Preparedness Act, in March 2026 and the bill received Senate Veterans' Affairs Committee hearing activity in April 2026. That is a serious same-term legislative effort directly matching the promised Office of Novel Therapeutics. However, the evidence shows only introduction, referral, and hearings, with no enactment, VA implementation, or actual establishment of the office. Because the promised outcome has not been delivered, this should be scored as never with an effort badge rather than delivered or partial.
Senator Sheehy introduced and championed the Veterans Health Administration Novel Therapeutics Preparedness Act, which would establish a dedicated Office of Novel Therapeutics within the VA. The bill was introduced, co-sponsored, and referred to committee, showing real legislative effort. However, the evidence shows only introduction and referral, with no confirmation of enactment or implementation of the promised office within the relevant term. Therefore, while effort is clear, the promise was not delivered.